Table 3. Comparison of Patient-Reported and Performance-Related Summary Scores by Treatment Groupa.
| Measure by treatment group | Baseline | Postoperative month | ||
|---|---|---|---|---|
| 1 | 3 | 6 | ||
| ADLb | ||||
| RARC | ||||
| No. of patients | 133 | 123 | 109 | 103 |
| Estimated score, mean (95% CI) | 7.3 (7.1-7.6) | 7.7 (7.3-8.0) | 7.4 (7.1-7.7) | 7.3 (7.1-7.5) |
| ORC | ||||
| No. of patients | 138 | 125 | 105 | 103 |
| Estimated score, mean (95% CI) | 7.3 (7.1-7.6) | 7.9 (7.5-8.2)c | 7.5 (7.2-7.8) | 7.2 (7.0-7.5) |
| iADLd | ||||
| RARC | ||||
| No. of patients | 132 | 120 | 105 | 101 |
| Estimated score, mean (95% CI) | 9.0 (8.5-9.5) | 10.8 (10.0-11.6)g | 9.4 (8.8-10.0) | 9.2 (8.7-9.8) |
| ORC | ||||
| No. of patients | 136 | 122 | 104 | 102 |
| Estimated score, mean (95% CI) | 9.4 (8.9-9.9) | 11.3 (10.5-12.1)c | 9.8 (9.1-10.4) | 9.2 (8.6-9.7) |
| TUGWT, se | ||||
| RARC | ||||
| No. of patients | 122 | 96 | 83 | 81 |
| Estimated, mean (95% CI) | 12.3 (10.3-14.3) | 14.0 (11.9-16.0)g | 12.1 (10.1-14.0) | 12.0 (9.9-14.0) |
| ORC | ||||
| No. of patients | 125 | 102 | 83 | 81 |
| Estimated, mean (95% CI) | 13.2 (11.1-15.2) | 14.9 (12.8-17.0)c | 13.4 (11.4-15.4) | 13.0 (10.9-15.1) |
| HGS, kgf | ||||
| RARC | ||||
| No. of patients | 127 | 104 | 90 | 86 |
| Estimated, mean (95% CI) | 31.1 (28.4-33.8) | 28.7 (26.0-31.3)g | 29.0 (26.3-31.7) | 29.8 (26.9-32.7) |
| ORC | ||||
| No. of patients | 132 | 112 | 88 | 86 |
| Estimated, mean (95% CI) | 32.4 (29.7-35.1) | 29.2 (26.5-31.9)c | 28.8 (26.3-31.6)c | 31.2 (28.2-34.2) |
Abbreviations: ADL, activities of daily living; HGS, hand grip strength; iADL, instrumental activities of daily living; ORC, open radical cystectomy; RARC, robot-assisted radical cystectomy; TUGWT, Timed Up & Go walking test.
The estimated means and 95% CIs are calculated from mixed models including time, group, diversion, time × group and time × diversion interactions, age, sex, body mass index, Eastern Cooperative Oncology Group performance status, T stage, and perioperative chemotherapy and accounting for site in the random-effect component of the model.
Scores range from 7 to 21, with higher scores indicating greater disability.
P ≤ .05, mean difference compared with baseline, statistically significant at the 5% significance using the Bonferroni adjustment for multiple comparisons.
Scores range from 8 to 24, with higher scores indicating greater disability.
Higher scores indicate worse performance.
Higher scores indicate better performance.
P ≤ .05, mean difference compared with baseline, statistically significant at the 5% significance using the Bonferroni adjustment for multiple comparisons.